GGrantIndex
Sort

48,018 grants matching immunotherapy

Context-specific functions of genes and cells

$452,762
Sridhar Hannenhalli · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

NextGen - CHOP

$452,749
John M Maris · Children'S Hosp Of Philadelphia · OT2 · FY2025 · CA

Enhancement of stem cell transplants using CAR.CD30-redirected T lymphocytes

$452,675
Barbara Savoldo · Baylor College Of Medicine · R01 · FY2014 · HL

Molecular Mechanisms in Gastrointestinal Stromal Tumor

$452,667
Ronald P Dematteo · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA

DNA damage response and cancer immunity

$452,659
Christopher J. Bakkenist · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA

Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy

$452,588
Taha Merghoub · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA

From the Past to the Future: Chimeric Antigen Receptor T cells for Lymphoid Malignancies

$452,562
Joseph Anthony Fraietta · University Of Pennsylvania · P01 · FY2025 · CA

SBIR Phase II: Hybrid Inorganic/Organic Ion Exchange Material for the 227Ac/223Ra Generator

$452,553
Hariprasad Gali · Lynntech, Inc · · FY2005 · TIP

Targeting Tregs in the solid tumor microenvironment by modulating metabolite signaling

$452,544
Sinã‰ad Kinsella · Fred Hutchinson Cancer Center · R21 · FY2024 · CA

Bispecific antibodies in multiple myeloma: understanding therapy resistance through imaging

$452,540
Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R21 · FY2025 · CA

Targeting CD5 on Tumor-associated T and B cells to improve PD-1 blockade in Breast Cancer

$452,540
Chunyan Zhang · Beckman Research Institute/City Of Hope · R21 · FY2020 · CA

Development and function of CD4+ memory T cells during malaria

$452,505
Noah Sullivan Butler · University Of Iowa · R01 · FY2025 · AI

Regulation of Plasmodium-specific CD4+ T cells

$452,505
Noah Sullivan Butler · University Of Iowa · R01 · FY2025 · AI

Metabolomics Technologies to Advance Biomedical Research

$452,500
Gary E Siuzdak · Scripps Research Institute, The · R35 · FY2024 · GM

HLA-DR Targeted Synthetic High Affinity Ligands

$452,489
University Of California Davis · P01 · FY2004 · CA

Molecular dissecting and targeting YAP1 mediated cancer stemness and immune suppression in advanced gastric adenocarcinoma

$452,423
Shumei Song · Coriell Institute For Medical Research · R01 · FY2023 · CA

Tumor and Immune Programming of Tumor-Associated Endothelium

$452,421
Eugene C Butcher · Palo Alto Veterans Instit For Research · R01 · FY2019 · CA

PROTEINS IN MULTIPLE MYELOMA AND RELATED BLOOD DISEASES

$452,412
University Of Tennessee Knoxville · R01 · FY2002 · CA

Microfluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsy

$452,315
Mehmet Toner · Massachusetts General Hospital · R01 · FY2021 · CA

Ultrasound-controlled remote activation of CAR T cells for localized tumor immunotherapy

$452,295
Yingxiao Wang · University Of Southern California · R01 · FY2023 · EB

Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer

$452,277
Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2020 · CA

Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer

$452,277
Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2021 · CA

E2A/HEB MEDIATED TRANSCRIPTIONAL REGULATION IN T CELL DEVELOPMENT

$452,251
Yuan Zhuang · Duke University · R01 · FY2018 · GM

Genomics and Computational Biology Shared Resource

$452,240
Kelly A Frazer · University Of California, San Diego · P30 · FY2023 · CA

Mathematical Model-Guided Adoptive Immunotherapy in Bladder Cancer

$452,237
Katarzyna Anna Rejniak · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA